Immunology and allergy researchers

Arne Svejgaard

Arne Svejgaard (1937–2016) was a Danish physician and immunologist who, with Flemming Kissmeyer-Nielsen, helped clarify the HLA tissue-type system, mapping its associations with diseases from psoriasis to diabetes.

Atsushi Kumanogoh

Atsushi Kumanogoh (熊ノ郷淳), born 1966, is a Japanese immunologist known for discovering immune semaphorins and serving as the 19th president of The University of Osaka since 2025.

Ban‐Hock Toh

Ban-Hock Toh, also known as B H Toh, is an Australian immunologist and Emeritus Professor of Medicine at Monash, known for work on autoimmune gastritis and pernicious anemia.

Bart N. Lambrecht

Bart N. Lambrecht, also known as Bart Lambrecht, is a Belgian physician-scientist in immunology and pulmonology, professor at Ghent University and director of the VIB-UGent Center for Inflammation Research.

Benjamin J. Marsland

Benjamin J. Marsland is a New Zealand-born immunologist and professor at Monash University in Melbourne who studies how gut and lung microbes shape asthma and lung transplant failure.

Beverly H. Koller

Beverly H. Koller is a molecular geneticist and Professor of Genetics at the University of North Carolina at Chapel Hill who builds gene-targeted and humanized mouse models of disease.

Bodo Grimbacher

Bodo Grimbacher is a German physician-scientist in clinical immunology at the Medical Center – University of Freiburg, known for identifying genetic causes of primary immunodeficiencies such as hyper-IgE syndrome.

Brigitte A. Askonas

Brigitte A. Askonas was an Austrian-born British immunologist who first cloned B cells and headed the immunology division at London's National Institute for Medical Research.

Bruce L. Zuraw

Bruce L. Zuraw is an American allergy and immunology physician-scientist, Professor of Medicine at UC San Diego and director of the US HAEA Angioedema Center, known for hereditary angioedema research.

Bruce S. Bochner

Bruce S. Bochner is an American allergist and immunologist who co-discovered Siglec-8, an inhibitory receptor on eosinophils and mast cells, led Johns Hopkins' allergy division, and co-founded Allakos.

Byron H. Waksman

Byron H. Waksman, also known as B H Waksman, was an American immunologist who pioneered neuroimmunology, demonstrated the thymus's role in immune tolerance, and taught at Harvard and Yale.

Carl Nathan

Carl F. Nathan is an American immunologist and microbiologist at Weill Cornell Medical College whose work defined how macrophages are activated to kill microbes, including tuberculosis research.

César Milstein

César Milstein (1927–2002) was an Argentine-born immunologist at Cambridge's MRC Laboratory of Molecular Biology who, with Georges Köhler, developed the hybridoma technique for monoclonal antibodies, earning the 1984 Nobel Prize in Physiology or Medicine.

Cezmi A. Akdiş

Cezmi A. Akdis is a Turkish physician-scientist in immunology and allergy who directs the Swiss Institute of Allergy and Asthma Research in Davos and is a University of Zurich professor.

Charles A. Dinarello

Charles A. Dinarello is an immunologist who discovered, purified, and cloned interleukin-1, a founding father of cytokine biology, and a professor at the University of Colorado.

Charles G. Cochrane

Charles G. Cochrane, born 1930, is an American immunologist at Scripps Research known for work on immune complex disease and the lung surfactant protein behind the drug Surfaxin.

Charles Kellaway

Charles Halliley Kellaway (1889–1952) was an Australian medical researcher who directed the Walter and Eliza Hall Institute for 21 years and produced Australia's first commercial antivenom.

Charles R. Mackay

Charles R. Mackay is an Australian immunologist, elected a Fellow of the Australian Academy of Science in 2009, known for lymphocyte migration and the 2009 Nature finding that short-chain fatty acids from gut bacteria regulate inflammation.

Charles W. Parker (immunologist)

Charles Ward Parker (1930–2013) was an American immunologist and allergist who founded Washington University's allergy division, identified the chemical basis of penicillin allergy, and helped classify slow reacting substance as a leukotriene.

Cheng Zhu

Cheng Zhu (朱橙) is a biomedical engineer at Georgia Tech known for the direct observation of catch bonds in cell-adhesion molecules and for showing that force triggers T-cell signaling.

Chester A. Alper

Chester A. Alper (1931–2024) was an American immunologist and pediatrician at Harvard Medical School and Boston Children's Hospital who pioneered complement genetics and the study of extended haplotypes in the MHC.

Christoph Hess

Christoph Hess is a Swiss clinical immunologist and immunometabolism researcher, born 1970 in Zurich, who holds professorships at the University of Basel and the University of Cambridge.

Claude Griscelli

Claude Griscelli (1936–2026) was a French pediatrician and immunologist who described Griscelli syndrome in 1978, built pediatric immunology at Hôpital Necker in Paris, led Inserm, and founded the Institut Imagine.

Clemens von Pirquet

Clemens von Pirquet (1874–1929) was an Austrian pediatrician who coined the term "allergy" in 1906, devised the first tuberculin skin test, and held the chair of pediatrics at the University of Vienna.

Cliona M. Rooney

Cliona M. Rooney is an immunologist and virologist at Baylor College of Medicine in Houston known for developing EBV-specific T-cell therapy, now standard of care in Europe, for EBV-associated lymphomas.

Clive Wood

Clive R. Wood is a British-trained immunologist credited with discovering the PD-1: PD-L1/PD-L2 cancer immunotherapy pathway, who led discovery research at Boehringer Ingelheim before joining OrbiMed in 2025.

Craig Gérard

Craig Gérard, also published as Craig Gerard, is a physician and immunology researcher at Boston Children's Hospital and Harvard Medical School known for cloning the C5a receptor.

Dale T. Umetsu

Dale T. Umetsu is an American physician-scientist and immunologist known for identifying the TIM gene family and NKT cells in asthma, and for professorships at Harvard and Stanford.

Dana R. Leach

Dana R. Leach is an immunologist who, as a postdoctoral fellow in James Allison's lab at UC Berkeley, was first author of the 1996 Science paper showing CTLA-4 blockade cures tumors in mice.